Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00003690

Trial Description

start of 1:1-Block title

Title

Euthymic Therapy: a Randomised Controlled Trial

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Investigation of a cognitive behavioural resource-strengthening group intervention program which aims to increase hedonic experiences such as joy and happiness. We hope to find a comparable effect in treatment of patients with remaining depression symptoms.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Evaluation of a patient's ressource srengthening psychotherapeutic intervention in treatment of residual depression symptoms

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00003690
  •   2012/04/02
  •   [---]*
  •   yes
  •   Approved
  •   EA1/172/06, Ethik-Kommission der Charité -Universitätsmedizin Berlin-
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   F32 -  Depressive episode
  •   F33 -  Recurrent depressive disorder
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Euthymic therapy, group intervention, 7 weekly sessions à 50 min
  •   psychoeducation, group therapy, 7 weekly sessions à 50 min
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Double or multiple blind
  •   [---]*
  •   Active control
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Our project thus aimes to assess the effects of ET on reduction of depressive symptoms (HAMD-21, BDI), anhedonia (TAF) and a patient's health resources (MR FSF) in a randomized, controlled, parallel-group design. We expect ET to reduce depressive residual symptoms and anhedonia and improve self care as effectively as the validated reference treatment (psychoeducation). 3 measuring times: baseline, post intervention an follow-up (after 3 month).
Following questionaires were used:
• Hamilton Depression Scale (HAMD)
• Tübinger-Anhedonie-Fragebogen (TAF)
• Becks Depressions Inventar (BDI II)
• Marburger Skalen zur Selbstfürsorge (MR FSF)

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Additionally we expect an increase in following parameters: leisure activities (Checkliste der Freizeitaktivitäten, CFA), liefe-satisfaction (Lebenszufriedenheitsbogen, LZF), pleasure (Genussfragebogen, SFS), general state of health (Fragebogen zum allg. Gesundheitszustand), SF-36), self-efficacy (Fragebogen zum Selbstwirksamkeitserleben, SWE), locus of control (Fragebogen zur Erhebung von Kontrollüberzeugungen zu Krankheit und Gesundheit, KKG), sense of coherence (Marburger Skalen zum Kohärenzsinn, MR SOC).
3 measuring times: baseline, post intervention an follow-up (after 3 month).

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2007/10/24
  •   44
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Diagnosis of depression (ICD-10: F32, F33) partialremission (HAMD-21 depression score of </= 9) or a reduction of depression severity by 50% (HAMD) from the peak during inpatient treatment. Psychiatric treatment as usual remained, and it was ensured that no change in medication occurred within two weeks prior to the start of the group intervention.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

History of bipolar disorder, cyclothymia, schizophrenia, schizoaffective disorder, organic brain damage or substance abuse/dependence. Participation in a pharmaceutical study and ongoing individual psychotherapy were further exclusion criteria as well as borderline (ICD-10: F60.3) or antisocial personality disorders (ICD-10: F60.2).

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Charité Campus Charité Mitte
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Charité Campus Charité Mitte
    • Ms.  Dipl.-Psych.  Julia   Kiermeir 
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Charité Campus Charité Mitte
    • Ms.  Dipl.-Psych.   Julia  Kiermeir 
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Charité Campus Charité Mitte
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2009/05/15
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.